Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Movano Inc MOVE

Movano Inc., doing business as Movano Health, is engaged in developing a suite of healthcare solutions to bring medical-grade data to the forefront of wearables. Its devices deliver data to both customers and enterprises, capturing a comprehensive picture of an individual’s health data and translating it into personalized and intelligent insights. Its product in development is the Evie Ring, which is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one’s health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It is also developing System-on-a-Chip (SoC) designed specifically for blood pressure or continuous glucose monitoring (CGM) systems.


NDAQ:MOVE - Post by User

<< Previous
Bullboard Posts
Post by whytestockson Nov 04, 2024 7:15pm
33 Views
Post# 36296241

Movano Health Submits Response to FDA as Part of Final Revie

Movano Health Submits Response to FDA as Part of Final Revie
News; $MOVE Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMEDMovano Health Submits Response to FDA as Part of Final Review Phase for EvieMED PR Newswire Company remains optimistic on the potential for this pioneering healthcare solution PLEASANTON, Calif. , Nov. 4, 2024 /PRNewswire/ -- Movano Health (NASDAQ...MOVE - Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED

<< Previous
Bullboard Posts